Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Accumulated Expenses (2018 - 2022)

AdaptHealth (AHCO) has 5 years of Accumulated Expenses data on record, last reported at $50.5 million in Q3 2022.

  • For Q3 2022, Accumulated Expenses rose 24.84% year-over-year to $50.5 million; the TTM value through Sep 2022 reached $50.5 million, up 24.84%, while the annual FY2021 figure was $34.4 million, 28.7% up from the prior year.
  • Accumulated Expenses reached $50.5 million in Q3 2022 per AHCO's latest filing, up from $28.9 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $50.5 million in Q3 2022 and bottomed at $20609.0 in Q2 2018.
  • Average Accumulated Expenses over 5 years is $20.4 million, with a median of $17.6 million recorded in 2020.
  • Peak YoY movement for Accumulated Expenses: surged 10687.75% in 2019, then tumbled 32.66% in 2022.
  • A 5-year view of Accumulated Expenses shows it stood at $9.1 million in 2018, then surged by 34.76% to $12.3 million in 2019, then surged by 116.76% to $26.7 million in 2020, then grew by 28.7% to $34.4 million in 2021, then surged by 47.04% to $50.5 million in 2022.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $50.5 million in Q3 2022, $28.9 million in Q2 2022, and $38.9 million in Q1 2022.